Sodium (S)-2-amino-3-((((R)-2,3-bis(dodecanoyloxy)propoxy)oxidophosphoryl)oxy)propanoate

Catalog No. :
ACLUKB504
CAS No. :
208757-51-1
Molecular Formula :
C30H56NNa2O10P
Molecular Weight :
667.73

IUPAC Name:sodium O-(((R)-2,3-bis(dodecanoyloxy)propoxy)oxidophosphoryl)-L-serinate

Sodium (S)-2-amino-3-((((R)-2,3-bis(dodecanoyloxy)propoxy)oxidophosphoryl)oxy)propanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$121.00Login to see priceIn stockInquiry
100mg98%$196.00Login to see priceIn stockInquiry
250mg98%$347.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium (S)-2-amino-3-((((R)-2,3-bis(dodecanoyloxy)propoxy)oxidophosphoryl)oxy)propanoate
IUPAC Namesodium O-(((R)-2,3-bis(dodecanoyloxy)propoxy)oxidophosphoryl)-L-serinate
Molecular FormulaC30H56NNa2O10P
Molecular Weight667.73
SMILESCCCCCCCCCCCC(O[C@@H](COP(OC[C@@H](C([O-])=O)N)([O-])=O)COC(CCCCCCCCCCC)=O)=O.[Na+].[Na+]
InChI KeySFFNDGPJOWQUTH-IBUTWNQASA-L
Synonym12:0 PS; 1,2-didodecanoyl-sn-glycero-3-phospho-L-serine (sodium salt); DLPS; PS(12:0/12:0); 1,2-dilauroyl-sn-glycero-3-phospho-L-serine (sodium salt)
CAS No.208757-51-1
PubChem CID118988877

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLUKB504 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLUKB504 route product structure diagram
    ACLUKB504208757-51-1 In Stock
Inquiry

2. ACLUKB504 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLUKB504 route product structure diagram
    ACLUKB504208757-51-1 In Stock
Inquiry

Comments (0)